Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Endava plc (NYSE:DAVA - Free Report) by 22.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,533,111 shares of the company's stock after acquiring an additional 842,433 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 7.68% of Endava worth $140,073,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of DAVA. Assetmark Inc. boosted its holdings in shares of Endava by 93.1% in the 4th quarter. Assetmark Inc. now owns 985 shares of the company's stock valued at $30,000 after buying an additional 475 shares in the last quarter. Blue Trust Inc. raised its holdings in Endava by 28.5% in the 4th quarter. Blue Trust Inc. now owns 1,494 shares of the company's stock valued at $46,000 after acquiring an additional 331 shares during the last quarter. Quadrant Capital Group LLC grew its stake in Endava by 114.2% during the fourth quarter. Quadrant Capital Group LLC now owns 1,474 shares of the company's stock worth $46,000 after buying an additional 786 shares during the period. State of Tennessee Department of Treasury purchased a new position in shares of Endava in the 4th quarter valued at $100,000. Finally, PNC Financial Services Group Inc. raised its position in Endava by 60.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,086 shares of the company's stock valued at $126,000 after purchasing an additional 1,538 shares during the period. Hedge funds and other institutional investors own 62.23% of the company's stock.
Wall Street Analysts Forecast Growth
DAVA has been the subject of a number of analyst reports. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $18.00 price objective on shares of Endava in a research report on Monday, May 19th. Susquehanna cut their target price on shares of Endava from $50.00 to $42.00 and set a "positive" rating on the stock in a research note on Tuesday, May 20th. Morgan Stanley raised their price target on shares of Endava from $33.00 to $35.00 and gave the stock an "equal weight" rating in a research report on Friday, January 31st. Guggenheim dropped their price objective on shares of Endava from $40.00 to $28.00 and set a "buy" rating on the stock in a research note on Tuesday, May 13th. Finally, Needham & Company LLC lowered their price target on shares of Endava from $22.00 to $18.00 and set a "buy" rating for the company in a research report on Thursday, May 15th. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $26.75.
Get Our Latest Analysis on DAVA
Endava Price Performance
Shares of DAVA traded down $0.28 during trading hours on Friday, reaching $15.14. The stock had a trading volume of 578,514 shares, compared to its average volume of 536,010. The stock has a market capitalization of $893.97 million, a PE ratio of 138.71, a PEG ratio of 2.26 and a beta of 1.25. Endava plc has a 12 month low of $14.00 and a 12 month high of $34.94. The company's 50-day moving average is $17.80 and its two-hundred day moving average is $25.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 1.90.
About Endava
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Featured Stories
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
